It may be the vaccine of the future, a nasal spray that would entirely prevent COVID-19 infections by delivering a boost of immunity right where the virus.
A nasal spray to treat adult COVID-19 patients has been launched in India after Mumbai-based developers Glenmark Pharmaceuticals received marketing clearances from the Drugs Controller General of India as part of an accelerated approval process.
The Drugs Controller General of India (DCGI) has granted permission to Hyderabad-based biotechnology firm Bharat Biotech for intranasal booster dose trials, news agency ANI reported. The trials will be done at nine different sites.